Depending on the amount of data to process, file generation may take longer.

If it takes too long to generate, you can limit the data by, for example, reducing the range of years.

Article

Download BibTeX

Title

Amorphous Polymer–Phospholipid Solid Dispersions for the Co-Delivery of Curcumin and Piperine Prepared via Hot-Melt Extrusion

Authors

[ 1 ] Instytut Inżynierii Materiałowej, Wydział Inżynierii Materiałowej i Fizyki Technicznej, Politechnika Poznańska | [ P ] employee

Scientific discipline (Law 2.0)

[2.8] Materials engineering

Year of publication

2024

Published in

Pharmaceutics

Journal year: 2024 | Journal volume: vol. 16 | Journal number: no. 8

Article type

scientific article

Publication language

english

Keywords
EN
  • curcumin
  • piperine
  • amorphous solid dispersion
  • phospholipids
  • hot-melt extrusion
  • supersaturation
  • solubility-enabling formulation
  • bioavailability
Abstract

EN Curcumin and piperine are plant compounds known for their health-promoting properties, but their use in the prevention or treatment of various diseases is limited by their poor solubility. To overcome this drawback, the curcumin–piperine amorphous polymer–phospholipid dispersions were prepared by hot melt extrusion technology. X-ray powder diffraction indicated the formation of amorphous systems. Differential scanning calorimetry confirmed amorphization and provided information on the good miscibility of the active compound–polymer–phospholipid dispersions. Owing to Fourier-transform infrared spectroscopy, the intermolecular interactions in systems were investigated. In the biopharmaceutical properties assessment, the improvement in solubility as well as the maintenance of the supersaturation state were confirmed. Moreover, PAMPA models simulating the gastrointestinal tract and blood-brain barrier showed enhanced permeability of active compounds presented in dispersions compared to the crystalline form of individual compounds. The presented paper suggests that polymer–phospholipid dispersions advantageously impact the bioaccessibility of poorly soluble active compounds.

Pages (from - to)

999-1 - 999-20

DOI

10.3390/pharmaceutics16080999

URL

https://www.mdpi.com/1999-4923/16/8/999

License type

CC BY (attribution alone)

Open Access Mode

open journal

Open Access Text Version

final published version

Date of Open Access to the publication

at the time of publication

Ministry points / journal

100

Impact Factor

4,9 [List 2023]

This website uses cookies to remember the authenticated session of the user. For more information, read about Cookies and Privacy Policy.